> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Entrotech Wound Dressing
- URL: https://www.fdaweb.com/fda-clears-entrotech-wound-dressing/
- Published: 2016-01-25T12:00:00.000Z
- Updated: 2026-09-15T02:30:25.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5134546

> FDA has cleared an Entrotech Life 510(k) for its ChloraDerm, an edge-to-edge transparent film dressing to provide a chlorhexidine matrix for wound and catheter site protection for up to seven days. “Compared to common non-antimicrobial dressings ChloraDerm demonstrates substantially greater effectiveness against multi-drug-resistant organisms at one, three and seven days, without adding increased cost or complexity,” the company says.  
>  
> The product is designed to prevent central line-associated bloodstream infections which account for 40% of all healthcare associated infections annually, the company says. Microbial flora present on a patient's skin during the extended use of intravenous catheters can lead to the development of such infections. “ChloraDerm is used to cover and secure primary dressings and protect wounds caused by percutaneous medical devices,” it says.